Rimidi represents a group of medical and business professionals dedicated to providing serious hope for solving healthcare's most pressing problems. Rimidi enables personalized management of chronic health conditions. We're committed to bringing the tools, insights, and analytics needed at the front lines of care to make chronic disease management a successful collaboration between providers and patients.

Women Business Leaders of the U.S. Health Care Industry Foundation (WBL) is a nonprofit organization housing the premier network of women executives across the health care industry. WBL’s mission is to connect and convene senior executive women in health care to create meaningful cross-sector relationships, advance their careers, and harness their collective power to improve the industry.

PhD in Pharmacology. Dissertation: Hematopoietic stem cell mediated gene therapy for hemophilia A using high-expression factor VIII constructs. Member of the Medical School Executive Curriculum Committee 2002-2004. Medical School GPA: 3.8. Graduate School GPA: 4.0. Step 1: 247. Step 2CK: 236. MCAT: 38.

Using protein, rna and dna technologies, we isolated and identified a binding protein involved in post-transcriptional regulation of endothelial nitric oxide synthase, an important enzyme in endothelial cell regulation.

Worked in both laboratory and office environments using sophisticated means to recover, understand, and derive intelligence from all manner of foreign signals. While at Raytheon, I managed a research and development project involving several government agencies and contractors. Information about methodologies or results is classified.

Served as technical expert in communications technologies. Performed initial screening as well as in depth analysis of potential telecommunications portfolio companies including scientific feasibility and competitive analysis.